GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
MELBOURNE, Australia, March 27, 2023 -- Genetic Technologies Limited – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US... | March 27, 2023
United States Simon Morriss Genetic Technologies American Cancer Society Exchange Commission Genetic Technologies Limited
Source: marketscreener.com